BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 2868699)

  • 1. Sulphasalazine in rheumatoid arthritis: desensitising the patient with a skin rash.
    Bax DE; Amos RS
    Ann Rheum Dis; 1986 Feb; 45(2):139-40. PubMed ID: 2868699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulphasalazine desensitisation in patients with arthritis.
    McCarthy C; Coughlan R
    Ir J Med Sci; 1994 May; 163(5):238-9. PubMed ID: 7913919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desensitization to sulphasalazine in patients with arthritis.
    Koski JM
    Clin Exp Rheumatol; 1993; 11(2):169-70. PubMed ID: 8099541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulphasalazine desensitization in a paediatric patient with juvenile chronic arthritis.
    Kümmerle-Deschner J; Dannecker G
    Acta Paediatr; 1995 Aug; 84(8):952-4. PubMed ID: 7488828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Desensitization for sulfasalazine-induced skin rash in a patient with ulcerative colitis.
    Akahoshi K; Chijiiwa Y; Kabemura T; Okabe H; Akamine Y; Nawata H
    J Gastroenterol; 1994 Dec; 29(6):772-5. PubMed ID: 7874275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulphasalazine in rheumatoid arthritis: desensitising the patient with a skin rash.
    Farr M; Bacon PA
    Ann Rheum Dis; 1987 May; 46(5):421. PubMed ID: 2884936
    [No Abstract]   [Full Text] [Related]  

  • 7. Desensitization for sulfasalazine skin rash.
    Purdy BH; Philips DM; Summers RW
    Ann Intern Med; 1984 Apr; 100(4):512-4. PubMed ID: 6142671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulphasalazine desensitisation in rheumatoid arthritis.
    Farr M; Scott DL; Bacon PA
    Br Med J (Clin Res Ed); 1982 Jan; 284(6309):118. PubMed ID: 6119134
    [No Abstract]   [Full Text] [Related]  

  • 9. Toxicity of sulphasalazine in rheumatoid arthritis. Possible protective effect of rheumatoid factors and corticosteroids.
    Gran JT; Myklebust G
    Scand J Rheumatol; 1993; 22(5):229-32. PubMed ID: 7901898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerability of enteric-coated sulphasalazine in rheumatoid arthritis: results of a co-operating clinics study.
    Donovan S; Hawley S; MacCarthy J; Scott DL
    Br J Rheumatol; 1990 Jun; 29(3):201-4. PubMed ID: 1972633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatal neutropenic enterocolitis associated with sulphasalazine therapy for rheumatoid arthritis.
    Chakravarty K; Scott DG; McCann BG
    Br J Rheumatol; 1992 May; 31(5):351-3. PubMed ID: 1349846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double blind comparative study of sulphasalazine and hydroxychloroquine in rheumatoid arthritis: evidence of an earlier effect of sulphasalazine.
    Nuver-Zwart IH; van Riel PL; van de Putte LB; Gribnau FW
    Ann Rheum Dis; 1989 May; 48(5):389-95. PubMed ID: 2567150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does sulphasalazine cause folate deficiency in rheumatoid arthritis?
    Grindulis KA; McConkey B
    Scand J Rheumatol; 1985; 14(3):265-70. PubMed ID: 2864741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psoriasis-like skin reaction in a patient with rheumatoid arthritis after sulphasalazine therapy.
    Bliddal H; Stangerup M
    Clin Rheumatol; 1991 Jun; 10(2):178-80. PubMed ID: 1680596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low dose desensitisation does not reduce the toxicity of sulphasalazine in rheumatoid arthritis.
    McInnes IB; Porter D; Murphy EA; Thomson EA; Madhok R; Hunter JA; Pullar T; Capell HA
    Ann Rheum Dis; 1996 May; 55(5):328-30. PubMed ID: 8660109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypersensitivity reaction to sulfasalazine: skin rash, fever, hepatitis and activated lymphocytes.
    Leroux JL; Ghezail M; Chertok P; Blotman F
    Clin Exp Rheumatol; 1992; 10(4):427. PubMed ID: 1356682
    [No Abstract]   [Full Text] [Related]  

  • 17. DRESS syndrome induced by sulphasalazine in rheumatoid arthritis.
    Bejia I; Ben Hammouda S; Riahi K; Zinelabidine F; Mediouni B; Touzi M; Bergaoui N
    Joint Bone Spine; 2006 Dec; 73(6):764-5. PubMed ID: 16626997
    [No Abstract]   [Full Text] [Related]  

  • 18. The three week sulphasalazine syndrome.
    Brooks H; Taylor HG; Nichol FE
    Clin Rheumatol; 1992 Dec; 11(4):566-8. PubMed ID: 1362531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Severe drug hypersensitivity syndrome due to sulphasalazine in patient with rheumatoid arthritis].
    Gutierrez M; Filippucci E; Bugatti L; Bertolazzi C; Grassi W
    Reumatismo; 2009; 61(1):65-8. PubMed ID: 19370190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulphasalazine: a safe, effective agent for prolonged control of rheumatoid arthritis. A comparison with sodium aurothiomalate.
    Bax DE; Amos RS
    Ann Rheum Dis; 1985 Mar; 44(3):194-8. PubMed ID: 2858182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.